Home
VTRS
VTRS News

Latest Viatris Inc. (VTRS) News on July 26, 2024

3 Surprisingly Underrated Stocks to Buy Right Now

Motley Fool

7 hours ago

3 Surprisingly Underrated Stocks to Buy Right Now

Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain

ACCESSWIRE

3 days ago

Viatris 2023 Sustainability Report: Building Access Through a Global and Flexible Supply Chain

Viatris 2023 Sustainability Report: Our Strategy and Model for Sustainable Access to Medicine

ACCESSWIRE

8 days ago

Viatris 2023 Sustainability Report: Our Strategy and Model for Sustainable Access to Medicine

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks

16 days ago

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Viatris closes $3.37bn divestitures with OTC deal

Pharmaceutical Technology

22 days ago

Viatris closes $3.37bn divestitures with OTC deal

MT Newswires

23 days ago

Viatris Divests Over-the-Counter Business to Cooper Consumer Health

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

PR Newswire

23 days ago

Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture

MT Newswires

24 days ago

Viatris Says US Department of Justice's Antitrust Division No Longer Considers Mylan Subject of Investigation

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

PR Newswire

25 days ago

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation

Here's Why You May Invest in Theravance (TBPH) Stock Now

Zacks

a month ago

Here's Why You May Invest in Theravance (TBPH) Stock Now

Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List

ACCESSWIRE

a month ago

Viatris Named to TIME’s World’s Most Sustainable Companies 2024 List

Viatris Named to TIME's World's Most Sustainable Companies 2024 List

PR Newswire

a month ago

Viatris Named to TIME's World's Most Sustainable Companies 2024 List

MT Newswires

a month ago

Regeneron Pharmaceuticals Wins Injunctions Against Biosimilars to Eye Disease Drug Eylea

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

PR Newswire

2 months ago

Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

PR Newswire

2 months ago

Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors

PR Newswire

2 months ago

Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors

Viatris to Participate in the Jeffries Global Healthcare Conference

PR Newswire

2 months ago

Viatris to Participate in the Jeffries Global Healthcare Conference

Insider Sale: Chief Legal Officer Brian Roman Sells 89,419 Shares of Viatris Inc (VTRS)

GuruFocus.com

2 months ago

Insider Sale: Chief Legal Officer Brian Roman Sells 89,419 Shares of Viatris Inc (VTRS)

Viatris Inc's Dividend Analysis

GuruFocus.com

2 months ago

Viatris Inc's Dividend Analysis

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

ACCESSWIRE

2 months ago

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

PR Newswire

2 months ago

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates

Zacks

2 months ago

Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates

Argus Research

2 months ago

Analyst Report: Viatris Inc

Argus Research

2 months ago

Market Digest: AMT, FSLR, IEX, LNT, MGM, FTV, OTIS, VTRS

Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Viatris Inc. (NASDAQ:VTRS) Q1 2024 Earnings Call Transcript

Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...

GuruFocus.com

3 months ago

Viatris Inc. (VTRS) Q1 2024 Earnings: Aligns with EPS Projections Amidst Strategic Shifts and ...

MT Newswires

3 months ago

UBS Trims Viatris Price Target to $12 From $13, Maintains Neutral Rating

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Viatris Inc Earnings Call

Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast

Benzinga

3 months ago

Weak Sales From Lipitor, Norvasc Hurt Viatris' Q1 Earnings, Lowers Annual Forecast

Morningstar Research

3 months ago

Analyst Report: Viatris Inc.

Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down

Zacks

3 months ago

Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down

Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

3 months ago

Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Reuters

3 months ago

Viagra maker Viatris misses revenue estimates on weak demand for older drugs

Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates

Zacks

3 months ago

Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates

MT Newswires

3 months ago

Viatris' Q1 Adjusted Earnings, Revenue Decrease; 2024 Outlook Reduced

Associated Press Finance

3 months ago

Viatris: Q1 Earnings Snapshot

Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges

PR Newswire

3 months ago

Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges

Why Earnings Season Could Be Great for Viatris (VTRS)

Zacks

3 months ago

Why Earnings Season Could Be Great for Viatris (VTRS)

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Zacks

3 months ago

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?

Zacks

3 months ago

Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?

Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Zacks

3 months ago

Viatris (VTRS) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Viatris to Participate in the BofA Securities 2024 Health Care Conference

PR Newswire

3 months ago

Viatris to Participate in the BofA Securities 2024 Health Care Conference

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Zacks

3 months ago

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Viatris Expands Its Wellbeing Program With the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health

ACCESSWIRE

3 months ago

Viatris Expands Its Wellbeing Program With the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health

Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health

PR Newswire

3 months ago

Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health

MT Newswires

3 months ago

Delcath Systems Amends Supply, Manufacturing Agreement With Synerx Pharma, Mylan Teoranta for Melphalan Hydrochloride

11 Best Low Price Pharma Stocks To Invest In

Insider Monkey

3 months ago

11 Best Low Price Pharma Stocks To Invest In

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

Zacks

3 months ago

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Zacks

3 months ago

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Bill Miller’s Latest 13 Stock Picks

Insider Monkey

3 months ago

Bill Miller’s Latest 13 Stock Picks

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

PR Newswire

3 months ago

Viatris to Report First Quarter 2024 Financial Results on May 9, 2024

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

PR Newswire

3 months ago

Viatris Appoints Corinne Le Goff as Chief Commercial Officer

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

CNW Group

3 months ago

Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada

Reuters

4 months ago

UPDATE 1-UK watchdog says Theramex-Viatris deal raises competition concerns

Reuters

4 months ago

UK watchdog says Theramex-Viatris deal raises competition concerns

Reuters

4 months ago

UPDATE 1-Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

Reuters

4 months ago

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

GlobeNewswire

4 months ago

Ocuphire Announces the U.S. Commercial Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

PR Newswire

4 months ago

Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States

Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?

Zacks

4 months ago

Why Is Viatris (VTRS) Down 3.5% Since Last Earnings Report?

Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

PR Newswire

4 months ago

Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 03/18/2024

Is Viatris a Great Dividend Stock or Just a Value Trap?

Motley Fool

4 months ago

Is Viatris a Great Dividend Stock or Just a Value Trap?

2 Dirt Cheap Dividend Stocks to Buy and Hold

Motley Fool

5 months ago

2 Dirt Cheap Dividend Stocks to Buy and Hold

Reuters

5 months ago

UPDATE 2-US FDA declines to approve Viatris's injection for multiple sclerosis

Reuters

5 months ago

US FDA declines to approve Viatris's injection for multiple sclerosis

Viatris Inc's Dividend Analysis

GuruFocus.com

5 months ago

Viatris Inc's Dividend Analysis

Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)

GuruFocus.com

5 months ago

Insider Sell: President of Greater China Xiangyang Ni Sells 21,532 Shares of Viatris Inc (VTRS)

Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript

Insider Monkey

5 months ago

Viatris Inc. (NASDAQ:VTRS) Q4 2023 Earnings Call Transcript

13 Best Pharma Dividend Stocks To Buy in 2024

Insider Monkey

5 months ago

13 Best Pharma Dividend Stocks To Buy in 2024

Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise

Zacks

5 months ago

Viatris' (VTRS) Generic Declines in Q4, Yupleri Sales Rise

Argus Research

5 months ago

Analyst Report: Viatris Inc

Argus Research

5 months ago

Market Digest: M, NTAP, NYT, BCE, RHHBY, BHF, UBER, ALC, VTRS

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Viatris Inc Earnings Call

Morningstar Research

5 months ago

Analyst Report: Viatris Inc.

Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates

Zacks

5 months ago

Viatris' (VTRS) Q4 Earnings and Revenues Miss Estimates

Viatris (VTRS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks

5 months ago

Viatris (VTRS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Reuters

5 months ago

Viatris forecasts strong 2024 sales on higher demand for branded drugs

Viatris Inc (VTRS) Meets 2023 Financial Targets and Sets Course for Continued Growth in 2024

GuruFocus.com

5 months ago

Viatris Inc (VTRS) Meets 2023 Financial Targets and Sets Course for Continued Growth in 2024

Associated Press Finance

5 months ago

Viatris: Q4 Earnings Snapshot

Viatris pays $350M to gain two drugs from Idorsia

BioPharma Dive

5 months ago

Viatris pays $350M to gain two drugs from Idorsia

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

PR Newswire

5 months ago

Viatris Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration

PR Newswire

5 months ago

Viatris and Idorsia Enter Into Significant Global Research and Development Collaboration

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Zacks

5 months ago

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Viatris (VTRS) to Report Q4 Earnings: Is a Beat in Store?

Zacks

5 months ago

Viatris (VTRS) to Report Q4 Earnings: Is a Beat in Store?

Insights Into Viatris (VTRS) Q4: Wall Street Projections for Key Metrics

Zacks

5 months ago

Insights Into Viatris (VTRS) Q4: Wall Street Projections for Key Metrics

Chris Davis Reduces Stake in Viatris Inc

GuruFocus.com

5 months ago

Chris Davis Reduces Stake in Viatris Inc

Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates

Zacks

6 months ago

Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates

Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results

PR Newswire

6 months ago

Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results

Cathie Wood Stocks In 2024: Tesla Stock Reverses As Elon Musk Loses $56 Billion Pay Plan

Investor's Business Daily

6 months ago

Cathie Wood Stocks In 2024: Tesla Stock Reverses As Elon Musk Loses $56 Billion Pay Plan

General Mills Elects Two New Board Members

Business Wire

6 months ago

General Mills Elects Two New Board Members

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Motley Fool

6 months ago

A Motley Fool Co-Founder's Roller-Coaster Nvidia Story

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

GlobeNewswire

6 months ago

Automotive Telematics Market to Exceed USD 34.52 billion by 2031 | According to Transparency Market Research Analysis

Company News for Jan 26, 2024

Zacks

6 months ago

Company News for Jan 26, 2024

30 Most Affordable Beach Towns to Live in the US

Insider Monkey

6 months ago

30 Most Affordable Beach Towns to Live in the US

Life Time and HOKA Kick Off Extended Multi-Year Partnership During Miami Marathon Weekend Jan. 26-28 and Inside Athletic Country Clubs

PR Newswire

6 months ago

Life Time and HOKA Kick Off Extended Multi-Year Partnership During Miami Marathon Weekend Jan. 26-28 and Inside Athletic Country Clubs

AXP vs. BAM: Which Stock Is the Better Value Option?

Zacks

6 months ago

AXP vs. BAM: Which Stock Is the Better Value Option?

Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)

Insider Monkey

6 months ago

Here’s Why Greenlight Decided to Repurchase Viatris (VTRS)

FM:Systems Study Finds Most Business Leaders Want to End Alternative Work Arrangements, Return to Full-Time Office Attendance

PR Newswire

6 months ago

FM:Systems Study Finds Most Business Leaders Want to End Alternative Work Arrangements, Return to Full-Time Office Attendance

12 S&P 500 Stocks On the Move

Insider Monkey

6 months ago

12 S&P 500 Stocks On the Move

Share on Social Networks: